Royal Bank of Canada’s Lunai Bioworks LNAI Stock Holding History
Bought
Maintained
Sold
Other funds holding LNAI
NMC
VCM
VF
VFT
XT
Royal Bank of Canada's LNAI Position: Q1 2026 in Review
Royal Bank of Canada increased its Lunai Bioworks (LNAI) stake by 583% in Q1 2026, buying an estimated $174 and bringing the position to 41 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7598.
Royal Bank of Canada first reported a position in LNAI in Q4 2019 and has held it in 21 quarters since. The position peaked at $22K in Q2 2021. 27 funds tracked by Wall St. Rank hold LNAI as of Q1 2026.
- Royal Bank of Canada held 41 shares of Lunai Bioworks worth $0 as of Q1 2026.
- Royal Bank of Canada bought 35 Lunai Bioworks shares in Q1 2026, an estimated $174.
- Lunai Bioworks made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7598 holding.
- Royal Bank of Canada first reported a position in Lunai Bioworks in Q4 2019 and has held it in 21 quarters since.
- Royal Bank of Canada's Lunai Bioworks position peaked at $22K in Q2 2021.
- 27 funds tracked by Wall St. Rank held Lunai Bioworks as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.